U-Blot® Research Grade PraluzatamabCat. No. WA3388Request quote
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade PraluzatamabCat. No. WA3388
U-Blot® Research Grade PrafnosbartCat. No. WA3387
U-Blot® Research Grade PradusinstobartCat. No. WA3386
U-Blot® Research Grade PozelimabCat. No. WA3385
U-Blot® Research Grade povovetugCat. No. WA3384
U-Blot® Research Grade PovetaciceptCat. No. WA3383
U-Blot® Research Grade potravitugCat. No. WA3382
U-Blot® Research Grade posnafusp alfaCat. No. WA3381
U-Blot® Research Grade PosdinemabCat. No. WA3380
U-Blot® Research Grade PorustobartCat. No. WA3379
U-Blot® Research Grade PorgaviximabCat. No. WA3378
U-Blot® Research Grade ponumkibartCat. No. WA3377